Public Listings: Enhancing Cardiac AI’s Evidence Trail
The public listing of a company fundamentally alters the transparency surrounding its operational and clinical claims. While it provides a new layer of scrutiny through…
The public listing of a company fundamentally alters the transparency surrounding its operational and clinical claims. While it provides a new layer of scrutiny through…
A data platform earns trust the same way a clinical tool does: one reviewable result at a time. This requires an evidence trail built from…
If you want to know if an AI health company really believes its own pitch, ignore the marketing slicks and ask for the contract. An…
The promise of artificial intelligence in healthcare often outpaces the evidence. Claims of innovation, particularly in the competitive field of AI health companies, frequently center…
AI’s real job in healthcare isn’t finding ‘invisible patterns’, it’s about shortening timelines. Think about a standard 10-year clinical risk model versus a 10-day early…
If you want to know if a healthcare AI is a real breakthrough, you don’t read the press releases. You trace its path to the…
Too often, our “innovation scores” get dazzled by shiny new technology, rewarding novelty while ignoring demonstrated impact. In a field like cardiac AI, where clinical…
The difference between a personal health gadget and a device a doctor can act on is simple: a clear review trail. Collecting health data is…
You can’t trust a cost claim on its own. For any health plan finance team looking at a pilot program, the economic projection is worthless…
The field of healthcare AI is filled with stories of companies that crashed and burned, but the most instructive failures aren’t the obvious flameouts. They’re…